Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells.

(13)C metabolic flux analysis (MFA) is the most comprehensive means of characterizing cellular metabolic states. Uniquely labeled isotopic tracers enable more focused analyses to probe specific reactions within the network. As a result, the choice of tracer largely determines the precision with which one can estimate metabolic fluxes, especially in complex mammalian systems that require multiple substrates. Here we have experimentally determined metabolic fluxes in a tumor cell line, successfully recapitulating the hallmarks of cancer cell metabolism. Using these data, we computationally evaluated specifically labeled (13)C glucose and glutamine tracers for their ability to precisely and accurately estimate fluxes in central carbon metabolism. These methods enabled us to identify the optimal tracer for analyzing individual fluxes, specific pathways, and central carbon metabolism as a whole. [1,2-(13)C(2)]glucose provided the most precise estimates for glycolysis, the pentose phosphate pathway, and the overall network. Tracers such as [2-(13)C]glucose and [3-(13)C]glucose also outperformed the more commonly used [1-(13)C]glucose. [U-(13)C(5)]glutamine emerged as the preferred isotopic tracer for the analysis of the tricarboxylic acid (TCA) cycle. These results provide valuable, quantitative information on the performance of (13)C-labeled substrates and can aid in the design of more informative MFA experiments in mammalian cell culture.

[1]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[2]  G. Stephanopoulos,et al.  Metabolic flux analysis in a nonstationary system: fed-batch fermentation of a high yielding strain of E. coli producing 1,3-propanediol. , 2007, Metabolic engineering.

[3]  Daniel E Bauer,et al.  ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.

[4]  Wolfgang Wiechert,et al.  Experimental design principles for isotopically instationary 13C labeling experiments , 2006, Biotechnology and bioengineering.

[5]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[6]  M. Hellerstein,et al.  Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. , 1993, The American journal of physiology.

[7]  Xiao-Jiang Feng,et al.  Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy , 2008, Nature Biotechnology.

[8]  G. Stephanopoulos,et al.  Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. , 2007, Metabolic engineering.

[9]  J. Kelleher,et al.  Metabolomic and Mass Isotopomer Analysis of Liver Gluconeogenesis and Citric Acid Cycle , 2008, Journal of Biological Chemistry.

[10]  Yinjie J. Tang,et al.  Metabolic flux analysis of Shewanella spp. reveals evolutionary robustness in central carbon metabolism , 2009, Biotechnology and bioengineering.

[11]  Beckley K Nfor,et al.  Metabolic flux analysis of a glycerol-overproducing Saccharomyces cerevisiae strain based on GC-MS, LC-MS and NMR-derived C-labelling data. , 2007, FEMS yeast research.

[12]  U. Hofmann,et al.  Identification of metabolic fluxes in hepatic cells from transient 13C‐labeling experiments: Part I. Experimental observations , 2008, Biotechnology and bioengineering.

[13]  Gregory Stephanopoulos,et al.  Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line* , 2008, Journal of Biological Chemistry.

[14]  J. Kelleher,et al.  Isotopomer spectral analysis of triglyceride fatty acid synthesis in 3T3-L1 cells. , 1992, The American journal of physiology.

[15]  J. Kelleher,et al.  Quantitative analysis of acetoacetate metabolism in AS-30D hepatoma cells with 13C and 14C isotopic techniques. , 1997, The American journal of physiology.

[16]  C. Maranas,et al.  Identification of optimal measurement sets for complete flux elucidation in metabolic flux analysis experiments. , 2008, Biotechnology and bioengineering.

[17]  U. Sauer,et al.  Article number: 62 REVIEW Metabolic networks in motion: 13 C-based flux analysis , 2022 .

[18]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[19]  G. Stephanopoulos,et al.  Network rigidity and metabolic engineering in metabolite overproduction , 1991, Science.

[20]  Juho Rousu,et al.  Planning optimal measurements of isotopomer distributions for estimation of metabolic fluxes , 2006, Bioinform..

[21]  Dietmar Schomburg,et al.  A high-throughput method for microbial metabolome analysis using gas chromatography/mass spectrometry. , 2007, Analytical biochemistry.

[22]  Bhagwant Kaur Sekhon,et al.  High-throughput screening platform for anticancer therapeutic drug cytotoxicity. , 2008, Assay and drug development technologies.

[23]  Marc K Hellerstein,et al.  New stable isotope-mass spectrometric techniques for measuring fluxes through intact metabolic pathways in mammalian systems: introduction of moving pictures into functional genomics and biochemical phenotyping. , 2004, Metabolic engineering.

[24]  M. Lerner,et al.  [1,2-13C2]-D-Glucose Profiles of the Serum, Liver, Pancreas, and DMBA-Induced Pancreatic Tumors of Rats , 2005, Pancreas.

[25]  M. Magnuson,et al.  Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. , 2007, Cell metabolism.

[26]  Gregory Stephanopoulos,et al.  Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. , 2006, Metabolic engineering.

[27]  M. Cascante,et al.  Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA). , 2003, Blood.

[28]  Joseph J. Heijnen,et al.  Metabolic flux analysis of a glycerol‐overproducing Saccharomyces cerevisiae strain based on GC‐MS, LC‐MS and NMR‐derived 13C‐labelling data , 2007 .

[29]  Yinjie J. Tang,et al.  Advances in analysis of microbial metabolic fluxes via (13)C isotopic labeling. , 2009, Mass spectrometry reviews.

[30]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[31]  J. Nielsen,et al.  It Is All about MetabolicFluxes , 2003, Journal of bacteriology.

[32]  J. Liao,et al.  Global metabolic effects of glycerol kinase overexpression in rat hepatoma cells. , 2008, Molecular genetics and metabolism.

[33]  Wolfgang Wiechert,et al.  Computational tools for isotopically instationary 13C labeling experiments under metabolic steady state conditions. , 2006, Metabolic engineering.

[34]  Jamey D. Young,et al.  An elementary metabolite unit (EMU) based method of isotopically nonstationary flux analysis , 2008, Biotechnology and bioengineering.